Avante (FRA:H93) Research & Development: €0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:H93 Avante Corp FRA:H93
57 GF Score
Price €1.07
GF Value €0.66
! 4 Warning Signs
View Full Analysis

What is Avante Research & Development?

Avante FRA:H93 +1.52% 57 Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus rates FRA:H93 with a GF Score™ of 57/100 and a GF Value™ of €0.66. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Avante's Research & Development for the three months ended in Dec. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Avante  (FRA:H93) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Avante Research & Development Related Terms

Avante Research & Development Historical Data

* Premium members only.

The historical data trend for Avante's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avante Research & Development Chart

Avante Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Avante Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:H93
57GF Score
Avante Corp FRA:H93
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avante Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Avante (FRA:H93) has a Research & Development of €0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Avante and its competitors.
Is Avante's Research & Development too high?
Avante's current Research & Development is €0.00 Mil. Overall, Avante has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Avante's Research & Development compare to ALLE and MSA?
Avante's Research & Development of €0.00 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Business Services company?
A good Research & Development depends on the Business Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Avante and its competitors. Avante's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avante stock overvalued right now?
Avante (FRA:H93) has a current Research & Development of €0.00 Mil. The stock's GF Value™ is €0.66, compared to a current price of €1.07 — trading 61.8% above its estimated fair value. The current Research & Development is €0.00 Mil. Avante's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Avante (FRA:H93), the current Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Avante (FRA:H93) Overvalued in 2026?

Based on GuruFocus' analysis, Avante stock appears to be overvalued. The current stock price of €1.07 is trading 61.8% above its estimated GF Value™ of €0.66.

Key valuation signals for FRA:H93:

  • Research & Development: €0.00 Mil
  • GF Value™: €0.66 vs. price of €1.07 (61.8% above fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the FRA:H93 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Avante Business Description

Other Exchanges XX:Canada
Address 1959 Leslie Street, Toronto, ON, CAN, M3B 2M3
Avante Corp is engaged in the provision of security, monitoring, system integration, and technology solutions. Its reportable segments are Avante Security and NSSG. The majority of its revenue is derived from the Avante Security segment, which provides premium security services for residential customers in Toronto and Muskoka, Ontario. Avante Security's business provides a complete offering ranging from system design, sales, installations, and monitoring to services such as alarm response and patrols, personal protection, house staff training, and secure transportation. Geographically, the company generates maximum revenue from Canada, and the rest from the USA, Egypt, Ukraine, Germany, and other markets.
57GF Score

Get the complete analysis for FRA:H93

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.07
Price
€0.66
GF Value